Is Purdue's $270M Deal Beginning Of End For Opioid Cases?
One lawsuit down, thousands more to go. That's the upshot of Purdue Pharma's $270 million settlement of opioid litigation brought by Oklahoma — it's a momentous event, but whether it sends...To view the full article, register now.
Already a subscriber? Click here to view full article